Trial intelligence / Profile preview

Vitamin D and Phenylbutyrate in HIV

NCT01702974Phase 2Completed

Sponsor
Karolinska Institutet
Start
Sep 2012
Primary completion
Aug 2015
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

A Phase 2 trial of vitamin d, sodium phenylbutyrate in human immunodeficiency virus infection (HIV), sponsored by Karolinska Institutet. Started Sep 2012; status: completed.

02

Drugs

vitamin dsodium phenylbutyrate
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01702974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01702974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call